Issued Patents All Time
Showing 1–25 of 42 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12364766 | Bifunctional small molecules to target the selective degradation of circulating proteins | David Caianiello, Mengwen Zhang | 2025-07-22 |
| 12312621 | Reprogramming urokinase into an antibody-recruiting anticancer agent | Charles E. Jakobsche | 2025-05-27 |
| 12234256 | Molecular degraders of extracellular proteins | David Caianiello, Edward DERAMON | 2025-02-25 |
| 12168639 | Therapeutic DNP derivatives and methods using same | Gerald I. Shulman | 2024-12-17 |
| 12162892 | CD16a binding agents and uses thereof | Anna BUNIN, Lawrence G. Iben, Douglas Manion, Matthew Welsch | 2024-12-10 |
| 12128105 | Molecular degraders of extracellular proteins | David Caianiello, Edward DERAMON | 2024-10-29 |
| 12084517 | Chimeric small molecules for the recruitment of antibodies to cancer cells | Ryan Murelli, Andrew Zhang | 2024-09-10 |
| 12083181 | Bi-functional molecules to degrade circulating proteins | David Caianiello | 2024-09-10 |
| 12070479 | Decarboxylated cannabis compositions and methods of making the same | Alexander John Levine | 2024-08-27 |
| 12042542 | Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer | Patrick McEnaney, Kelly Fitzgerald | 2024-07-23 |
| 11920172 | Reprogramming urokinase into an antibody-recruiting anticancer agent | Charles E. Jakobsche | 2024-03-05 |
| 11858917 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | Christopher Parker | 2024-01-02 |
| 11767301 | Bi-functional molecules to degrade circulating proteins | David Caianiello | 2023-09-26 |
| 11725064 | Chimeric small molecules for the recruitment of antibodies to cancer cells | Ryan Murelli, Andrew Zhang | 2023-08-15 |
| 11597697 | Therapeutic DNP derivatives and methods using same | Gerald I. Shulman | 2023-03-07 |
| 11572370 | CD16A binding agents and uses thereof | Anna BUNIN, Lawrence G. Iben, Douglas Manion, Matthew Welsch | 2023-02-07 |
| 11472764 | Therapeutic DNP derivatives and methods using same | Gerald I. Shulman | 2022-10-18 |
| 11136316 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the Human Immunodeficiency Virus | Christopher Parker | 2021-10-05 |
| 11014992 | Chimeric small molecules for the recruitment of antibodies to cancer cells | Ryan Murelli, Andrew Zhang | 2021-05-25 |
| 10961527 | Reprogramming urokinase into an antibody-recruiting anticancer agent | Charles E. Jakobsche | 2021-03-30 |
| 10912836 | Synthetic antibody mimetic compounds (SyAMs) targeting cancer, especially prostate cancer | Patrick McEnaney, Kelly Fitzgerald | 2021-02-09 |
| 10780084 | Antibody-recruiting molecules for the treatment of cancer | H. Marie Loughran, Jeffrey Claude Pelletier, Allen B. Reitz, Matthew Welsch | 2020-09-22 |
| 10781161 | Therapeutic DNP derivatives and methods using same | Gerald I. Shulman | 2020-09-22 |
| 10703823 | Chimeric small molecules for the recruitment of antibodies to cancer cells | Ryan Murelli, Andrew Zhang | 2020-07-07 |
| 10703743 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | Christopher Parker | 2020-07-07 |